nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—breast cancer—bone cancer	0.27	0.431	CtDrD
Gemcitabine—kidney cancer—bone cancer	0.181	0.29	CtDrD
Gemcitabine—lung cancer—bone cancer	0.175	0.28	CtDrD
Gemcitabine—TYMS—Methotrexate—bone cancer	0.0683	0.339	CbGbCtD
Gemcitabine—ABCC10—Doxorubicin—bone cancer	0.0581	0.289	CbGbCtD
Gemcitabine—ABCC10—Methotrexate—bone cancer	0.0563	0.279	CbGbCtD
Gemcitabine—ABCB1—Cisplatin—bone cancer	0.00808	0.0401	CbGbCtD
Gemcitabine—ABCB1—Doxorubicin—bone cancer	0.00541	0.0269	CbGbCtD
Gemcitabine—ABCB1—Methotrexate—bone cancer	0.00524	0.026	CbGbCtD
Gemcitabine—DCK—Doxorubicin—Epirubicin—bone cancer	0.00061	0.519	CbGdCrCtD
Gemcitabine—DCK—Epirubicin—Doxorubicin—bone cancer	0.000565	0.481	CbGdCrCtD
Gemcitabine—Zalcitabine—CYP3A4—bone cancer	0.000206	0.598	CrCbGaD
Gemcitabine—Cytarabine—CYP3A4—bone cancer	0.000138	0.402	CrCbGaD
Gemcitabine—CMPK1—connective tissue—bone cancer	0.000135	0.0677	CbGeAlD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000133	0.00155	CbGpPWpGaD
Gemcitabine—RRM2—Fluoropyrimidine Activity—TP53—bone cancer	0.000131	0.00153	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000131	0.00153	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—DHFR—bone cancer	0.00013	0.00152	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000128	0.00149	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NDUFA12—bone cancer	0.000127	0.00149	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000125	0.00146	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000124	0.00145	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000124	0.00145	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000123	0.00144	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000123	0.00144	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—MDM2—bone cancer	0.000123	0.00144	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000123	0.00144	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000119	0.00139	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000118	0.00139	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000118	0.00138	CbGpPWpGaD
Gemcitabine—Myalgia—Cisplatin—bone cancer	0.000118	0.00141	CcSEcCtD
Gemcitabine—POLA1—E2F transcription factor network—PLAU—bone cancer	0.000118	0.00138	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000117	0.0014	CcSEcCtD
Gemcitabine—Liver function test abnormal—Methotrexate—bone cancer	0.000117	0.0014	CcSEcCtD
Gemcitabine—Discomfort—Cisplatin—bone cancer	0.000117	0.0014	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000115	0.00135	CbGpPWpGaD
Gemcitabine—Renal impairment—Doxorubicin—bone cancer	0.000115	0.00138	CcSEcCtD
Gemcitabine—Dermatitis bullous—Doxorubicin—bone cancer	0.000115	0.00137	CcSEcCtD
Gemcitabine—Face oedema—Epirubicin—bone cancer	0.000114	0.00137	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000114	0.00136	CcSEcCtD
Gemcitabine—Anaphylactic shock—Cisplatin—bone cancer	0.000113	0.00136	CcSEcCtD
Gemcitabine—Oedema—Cisplatin—bone cancer	0.000113	0.00136	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000113	0.00133	CbGpPWpGaD
Gemcitabine—POLD1—Synthesis of DNA—RB1—bone cancer	0.000113	0.00133	CbGpPWpGaD
Gemcitabine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000113	0.00135	CcSEcCtD
Gemcitabine—TYMS—E2F transcription factor network—PLAU—bone cancer	0.000113	0.00132	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000113	0.00132	CbGpPWpGaD
Gemcitabine—Infection—Cisplatin—bone cancer	0.000113	0.00135	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—RFC1—bone cancer	0.000112	0.00132	CbGpPWpGaD
Gemcitabine—Cardiac failure—Doxorubicin—bone cancer	0.000112	0.00134	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—ZW10—bone cancer	0.000112	0.00131	CbGpPWpGaD
Gemcitabine—Cerebrovascular accident—Doxorubicin—bone cancer	0.000112	0.00134	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle, Mitotic—RFC1—bone cancer	0.000112	0.00131	CbGpPWpGaD
Gemcitabine—Nervous system disorder—Cisplatin—bone cancer	0.000111	0.00133	CcSEcCtD
Gemcitabine—Thrombocytopenia—Cisplatin—bone cancer	0.000111	0.00133	CcSEcCtD
Gemcitabine—Blood creatinine increased—Epirubicin—bone cancer	0.000111	0.00133	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—TUBB4B—bone cancer	0.000111	0.0013	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TUBB4B—bone cancer	0.00011	0.00129	CbGpPWpGaD
Gemcitabine—Skin disorder—Cisplatin—bone cancer	0.00011	0.00132	CcSEcCtD
Gemcitabine—Hyperhidrosis—Cisplatin—bone cancer	0.00011	0.00131	CcSEcCtD
Gemcitabine—POLE—Synthesis of DNA—RB1—bone cancer	0.000109	0.00128	CbGpPWpGaD
Gemcitabine—Liver function test abnormal—Epirubicin—bone cancer	0.000109	0.00131	CcSEcCtD
Gemcitabine—Anorexia—Cisplatin—bone cancer	0.000108	0.00129	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—RFC1—bone cancer	0.000108	0.00126	CbGpPWpGaD
Gemcitabine—Hypokalaemia—Epirubicin—bone cancer	0.000108	0.00129	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—ZW10—bone cancer	0.000107	0.00125	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—CDK4—bone cancer	0.000107	0.00125	CbGpPWpGaD
Gemcitabine—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000107	0.00128	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000107	0.00128	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—TUBB4B—bone cancer	0.000106	0.00125	CbGpPWpGaD
Gemcitabine—POLD1—DNA Replication—RB1—bone cancer	0.000106	0.00124	CbGpPWpGaD
Gemcitabine—Hypotension—Cisplatin—bone cancer	0.000106	0.00127	CcSEcCtD
Gemcitabine—Face oedema—Doxorubicin—bone cancer	0.000106	0.00127	CcSEcCtD
Gemcitabine—CDA—Metabolism—NT5C3A—bone cancer	0.000106	0.00124	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000105	0.00123	CbGpPWpGaD
Gemcitabine—CDA—tendon—bone cancer	0.000105	0.0523	CbGeAlD
Gemcitabine—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000105	0.00125	CcSEcCtD
Gemcitabine—Pancytopenia—Methotrexate—bone cancer	0.000104	0.00124	CcSEcCtD
Gemcitabine—SLC28A3—bone marrow—bone cancer	0.000104	0.0518	CbGeAlD
Gemcitabine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000103	0.00124	CcSEcCtD
Gemcitabine—POLE—S Phase—CDK4—bone cancer	0.000103	0.00121	CbGpPWpGaD
Gemcitabine—RRM2—G1/S Transition—RB1—bone cancer	0.000103	0.00121	CbGpPWpGaD
Gemcitabine—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000103	0.0012	CbGpPWpGaD
Gemcitabine—Blood creatinine increased—Doxorubicin—bone cancer	0.000103	0.00123	CcSEcCtD
Gemcitabine—POLE—DNA Replication—RB1—bone cancer	0.000103	0.0012	CbGpPWpGaD
Gemcitabine—Influenza—Epirubicin—bone cancer	0.000102	0.00122	CcSEcCtD
Gemcitabine—Neutropenia—Methotrexate—bone cancer	0.000102	0.00122	CcSEcCtD
Gemcitabine—Paraesthesia—Cisplatin—bone cancer	0.000102	0.00122	CcSEcCtD
Gemcitabine—CDA—bone marrow—bone cancer	0.000101	0.0507	CbGeAlD
Gemcitabine—Liver function test abnormal—Doxorubicin—bone cancer	0.000101	0.00121	CcSEcCtD
Gemcitabine—Dyspnoea—Cisplatin—bone cancer	0.000101	0.00121	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000101	0.00118	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000101	0.00118	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—RFC1—bone cancer	0.000101	0.00118	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—ZW10—bone cancer	0.0001	0.00117	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—RFC1—bone cancer	9.99e-05	0.00117	CbGpPWpGaD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDK4—bone cancer	9.98e-05	0.00117	CbGpPWpGaD
Gemcitabine—Hypokalaemia—Doxorubicin—bone cancer	9.98e-05	0.00119	CcSEcCtD
Gemcitabine—POLE—G1/S Transition—RB1—bone cancer	9.89e-05	0.00116	CbGpPWpGaD
Gemcitabine—Aspartate aminotransferase increased—Doxorubicin—bone cancer	9.87e-05	0.00118	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	9.87e-05	0.00118	CcSEcCtD
Gemcitabine—Decreased appetite—Cisplatin—bone cancer	9.86e-05	0.00118	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	9.83e-05	0.00115	CbGpPWpGaD
Gemcitabine—Pneumonia—Methotrexate—bone cancer	9.81e-05	0.00117	CcSEcCtD
Gemcitabine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	9.81e-05	0.00115	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Cisplatin—bone cancer	9.79e-05	0.00117	CcSEcCtD
Gemcitabine—SLC29A2—tendon—bone cancer	9.78e-05	0.0489	CbGeAlD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.75e-05	0.00114	CbGpPWpGaD
Gemcitabine—Pancytopenia—Epirubicin—bone cancer	9.73e-05	0.00116	CcSEcCtD
Gemcitabine—POLA1—E2F transcription factor network—RB1—bone cancer	9.71e-05	0.00114	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	9.7e-05	0.00114	CbGpPWpGaD
Gemcitabine—Pain—Cisplatin—bone cancer	9.7e-05	0.00116	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Methotrexate—bone cancer	9.67e-05	0.00116	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Doxorubicin—bone cancer	9.67e-05	0.00116	CcSEcCtD
Gemcitabine—RRM1—Metabolism—NDUFA12—bone cancer	9.65e-05	0.00113	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—RFC1—bone cancer	9.65e-05	0.00113	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	9.64e-05	0.00113	CbGpPWpGaD
Gemcitabine—Renal failure—Methotrexate—bone cancer	9.59e-05	0.00115	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—ZW10—bone cancer	9.59e-05	0.00112	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDK4—bone cancer	9.58e-05	0.00112	CbGpPWpGaD
Gemcitabine—Neutropenia—Epirubicin—bone cancer	9.58e-05	0.00114	CcSEcCtD
Gemcitabine—Stomatitis—Methotrexate—bone cancer	9.51e-05	0.00114	CcSEcCtD
Gemcitabine—Influenza—Doxorubicin—bone cancer	9.48e-05	0.00113	CcSEcCtD
Gemcitabine—Sweating—Methotrexate—bone cancer	9.35e-05	0.00112	CcSEcCtD
Gemcitabine—Feeling abnormal—Cisplatin—bone cancer	9.34e-05	0.00112	CcSEcCtD
Gemcitabine—Haematuria—Methotrexate—bone cancer	9.3e-05	0.00111	CcSEcCtD
Gemcitabine—TYMS—E2F transcription factor network—RB1—bone cancer	9.3e-05	0.00109	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	9.29e-05	0.00109	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—RB1—bone cancer	9.29e-05	0.00109	CbGpPWpGaD
Gemcitabine—Hyperglycaemia—Epirubicin—bone cancer	9.24e-05	0.0011	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Methotrexate—bone cancer	9.23e-05	0.0011	CcSEcCtD
Gemcitabine—Pneumonia—Epirubicin—bone cancer	9.18e-05	0.0011	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	9.18e-05	0.00107	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	9.16e-05	0.00107	CbGpPWpGaD
Gemcitabine—Agranulocytosis—Methotrexate—bone cancer	9.11e-05	0.00109	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Epirubicin—bone cancer	9.05e-05	0.00108	CcSEcCtD
Gemcitabine—CMPK1—bone marrow—bone cancer	9.01e-05	0.0451	CbGeAlD
Gemcitabine—Pancytopenia—Doxorubicin—bone cancer	9e-05	0.00108	CcSEcCtD
Gemcitabine—Renal failure—Epirubicin—bone cancer	8.98e-05	0.00107	CcSEcCtD
Gemcitabine—CMPK1—spinal cord—bone cancer	8.97e-05	0.0449	CbGeAlD
Gemcitabine—POLE—S Phase—RB1—bone cancer	8.97e-05	0.00105	CbGpPWpGaD
Gemcitabine—Body temperature increased—Cisplatin—bone cancer	8.96e-05	0.00107	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Epirubicin—bone cancer	8.95e-05	0.00107	CcSEcCtD
Gemcitabine—Stomatitis—Epirubicin—bone cancer	8.9e-05	0.00106	CcSEcCtD
Gemcitabine—Neutropenia—Doxorubicin—bone cancer	8.86e-05	0.00106	CcSEcCtD
Gemcitabine—Haemoglobin—Methotrexate—bone cancer	8.8e-05	0.00105	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	8.78e-05	0.00103	CbGpPWpGaD
Gemcitabine—Haemorrhage—Methotrexate—bone cancer	8.76e-05	0.00105	CcSEcCtD
Gemcitabine—Sweating—Epirubicin—bone cancer	8.75e-05	0.00105	CcSEcCtD
Gemcitabine—POLE—tendon—bone cancer	8.72e-05	0.0436	CbGeAlD
Gemcitabine—Haematuria—Epirubicin—bone cancer	8.71e-05	0.00104	CcSEcCtD
Gemcitabine—Pharyngitis—Methotrexate—bone cancer	8.69e-05	0.00104	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—RB1—bone cancer	8.68e-05	0.00102	CbGpPWpGaD
Gemcitabine—Urinary tract disorder—Methotrexate—bone cancer	8.65e-05	0.00103	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Epirubicin—bone cancer	8.64e-05	0.00103	CcSEcCtD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—bone cancer	8.59e-05	0.001	CbGpPWpGaD
Gemcitabine—Urethral disorder—Methotrexate—bone cancer	8.59e-05	0.00103	CcSEcCtD
Gemcitabine—Hyperglycaemia—Doxorubicin—bone cancer	8.55e-05	0.00102	CcSEcCtD
Gemcitabine—Agranulocytosis—Epirubicin—bone cancer	8.52e-05	0.00102	CcSEcCtD
Gemcitabine—Pneumonia—Doxorubicin—bone cancer	8.5e-05	0.00102	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—TUBB4B—bone cancer	8.48e-05	0.000992	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—GNA11—bone cancer	8.46e-05	0.00099	CbGpPWpGaD
Gemcitabine—POLE—bone marrow—bone cancer	8.45e-05	0.0422	CbGeAlD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—bone cancer	8.44e-05	0.000987	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—EZH2—bone cancer	8.43e-05	0.000986	CbGpPWpGaD
Gemcitabine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	8.38e-05	0.001	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	8.34e-05	0.000976	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—RB1—bone cancer	8.33e-05	0.000975	CbGpPWpGaD
Gemcitabine—Renal failure—Doxorubicin—bone cancer	8.3e-05	0.000993	CcSEcCtD
Gemcitabine—Erythema multiforme—Methotrexate—bone cancer	8.28e-05	0.00099	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Doxorubicin—bone cancer	8.28e-05	0.00099	CcSEcCtD
Gemcitabine—Haemoglobin—Epirubicin—bone cancer	8.24e-05	0.000985	CcSEcCtD
Gemcitabine—Stomatitis—Doxorubicin—bone cancer	8.24e-05	0.000984	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	8.23e-05	0.000963	CbGpPWpGaD
Gemcitabine—Rhinitis—Epirubicin—bone cancer	8.22e-05	0.000982	CcSEcCtD
Gemcitabine—Haemorrhage—Epirubicin—bone cancer	8.2e-05	0.00098	CcSEcCtD
Gemcitabine—Asthenia—Cisplatin—bone cancer	8.14e-05	0.000973	CcSEcCtD
Gemcitabine—Pharyngitis—Epirubicin—bone cancer	8.14e-05	0.000972	CcSEcCtD
Gemcitabine—Cardiac disorder—Methotrexate—bone cancer	8.13e-05	0.000972	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—TUBB4B—bone cancer	8.12e-05	0.000951	CbGpPWpGaD
Gemcitabine—Sweating—Doxorubicin—bone cancer	8.1e-05	0.000968	CcSEcCtD
Gemcitabine—Urinary tract disorder—Epirubicin—bone cancer	8.09e-05	0.000968	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—RB1—bone cancer	8.08e-05	0.000946	CbGpPWpGaD
Gemcitabine—Oedema peripheral—Epirubicin—bone cancer	8.07e-05	0.000965	CcSEcCtD
Gemcitabine—Haematuria—Doxorubicin—bone cancer	8.06e-05	0.000963	CcSEcCtD
Gemcitabine—Connective tissue disorder—Epirubicin—bone cancer	8.05e-05	0.000963	CcSEcCtD
Gemcitabine—Urethral disorder—Epirubicin—bone cancer	8.04e-05	0.000961	CcSEcCtD
Gemcitabine—RRM1—Metabolism—NT5C3A—bone cancer	8e-05	0.000936	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	7.99e-05	0.000935	CbGpPWpGaD
Gemcitabine—Hepatobiliary disease—Doxorubicin—bone cancer	7.99e-05	0.000955	CcSEcCtD
Gemcitabine—RRM2—Metabolism—NDUFA12—bone cancer	7.95e-05	0.00093	CbGpPWpGaD
Gemcitabine—Angiopathy—Methotrexate—bone cancer	7.95e-05	0.00095	CcSEcCtD
Gemcitabine—Immune system disorder—Methotrexate—bone cancer	7.91e-05	0.000946	CcSEcCtD
Gemcitabine—POLD1—Metabolism—NDUFA12—bone cancer	7.9e-05	0.000925	CbGpPWpGaD
Gemcitabine—Mediastinal disorder—Methotrexate—bone cancer	7.89e-05	0.000944	CcSEcCtD
Gemcitabine—Agranulocytosis—Doxorubicin—bone cancer	7.88e-05	0.000942	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	7.88e-05	0.000923	CbGpPWpGaD
Gemcitabine—TYMS—connective tissue—bone cancer	7.87e-05	0.0393	CbGeAlD
Gemcitabine—Chills—Methotrexate—bone cancer	7.86e-05	0.000939	CcSEcCtD
Gemcitabine—POLA1—Synthesis of DNA—RB1—bone cancer	7.8e-05	0.000912	CbGpPWpGaD
Gemcitabine—Diarrhoea—Cisplatin—bone cancer	7.76e-05	0.000927	CcSEcCtD
Gemcitabine—Erythema multiforme—Epirubicin—bone cancer	7.75e-05	0.000926	CcSEcCtD
Gemcitabine—Alopecia—Methotrexate—bone cancer	7.74e-05	0.000925	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—RFC1—bone cancer	7.69e-05	0.0009	CbGpPWpGaD
Gemcitabine—Erythema—Methotrexate—bone cancer	7.62e-05	0.000911	CcSEcCtD
Gemcitabine—Haemoglobin—Doxorubicin—bone cancer	7.62e-05	0.000911	CcSEcCtD
Gemcitabine—Cardiac disorder—Epirubicin—bone cancer	7.61e-05	0.000909	CcSEcCtD
Gemcitabine—Rhinitis—Doxorubicin—bone cancer	7.6e-05	0.000909	CcSEcCtD
Gemcitabine—Haemorrhage—Doxorubicin—bone cancer	7.58e-05	0.000907	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—TUBB4B—bone cancer	7.58e-05	0.000887	CbGpPWpGaD
Gemcitabine—Pharyngitis—Doxorubicin—bone cancer	7.53e-05	0.0009	CcSEcCtD
Gemcitabine—POLA1—tendon—bone cancer	7.52e-05	0.0376	CbGeAlD
Gemcitabine—Urinary tract disorder—Doxorubicin—bone cancer	7.49e-05	0.000895	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—ENO2—bone cancer	7.48e-05	0.000876	CbGpPWpGaD
Gemcitabine—Oedema peripheral—Doxorubicin—bone cancer	7.47e-05	0.000893	CcSEcCtD
Gemcitabine—Connective tissue disorder—Doxorubicin—bone cancer	7.45e-05	0.000891	CcSEcCtD
Gemcitabine—Angiopathy—Epirubicin—bone cancer	7.44e-05	0.000889	CcSEcCtD
Gemcitabine—Urethral disorder—Doxorubicin—bone cancer	7.43e-05	0.000889	CcSEcCtD
Gemcitabine—DCK—Metabolism—NDUFA12—bone cancer	7.43e-05	0.000869	CbGpPWpGaD
Gemcitabine—Immune system disorder—Epirubicin—bone cancer	7.4e-05	0.000885	CcSEcCtD
Gemcitabine—Mediastinal disorder—Epirubicin—bone cancer	7.39e-05	0.000883	CcSEcCtD
Gemcitabine—Back pain—Methotrexate—bone cancer	7.38e-05	0.000882	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—RFC1—bone cancer	7.37e-05	0.000862	CbGpPWpGaD
Gemcitabine—Chills—Epirubicin—bone cancer	7.35e-05	0.000879	CcSEcCtD
Gemcitabine—POLA1—S Phase—CDK4—bone cancer	7.35e-05	0.000861	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—bone cancer	7.33e-05	0.000857	CbGpPWpGaD
Gemcitabine—Arrhythmia—Epirubicin—bone cancer	7.32e-05	0.000875	CcSEcCtD
Gemcitabine—POLA1—DNA Replication—RB1—bone cancer	7.31e-05	0.000856	CbGpPWpGaD
Gemcitabine—POLA1—bone marrow—bone cancer	7.28e-05	0.0364	CbGeAlD
Gemcitabine—TYMS—Cell Cycle—TUBB4B—bone cancer	7.26e-05	0.00085	CbGpPWpGaD
Gemcitabine—Alopecia—Epirubicin—bone cancer	7.24e-05	0.000866	CcSEcCtD
Gemcitabine—Vomiting—Cisplatin—bone cancer	7.21e-05	0.000862	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	7.19e-05	0.000842	CbGpPWpGaD
Gemcitabine—RRM2—tendon—bone cancer	7.18e-05	0.0359	CbGeAlD
Gemcitabine—Erythema multiforme—Doxorubicin—bone cancer	7.17e-05	0.000857	CcSEcCtD
Gemcitabine—Rash—Cisplatin—bone cancer	7.15e-05	0.000855	CcSEcCtD
Gemcitabine—Dermatitis—Cisplatin—bone cancer	7.14e-05	0.000854	CcSEcCtD
Gemcitabine—Erythema—Epirubicin—bone cancer	7.14e-05	0.000853	CcSEcCtD
Gemcitabine—Ill-defined disorder—Methotrexate—bone cancer	7.07e-05	0.000846	CcSEcCtD
Gemcitabine—SLC29A1—connective tissue—bone cancer	7.06e-05	0.0353	CbGeAlD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—bone cancer	7.05e-05	0.000825	CbGpPWpGaD
Gemcitabine—Anaemia—Methotrexate—bone cancer	7.05e-05	0.000842	CcSEcCtD
Gemcitabine—POLA1—G1/S Transition—RB1—bone cancer	7.04e-05	0.000824	CbGpPWpGaD
Gemcitabine—Cardiac disorder—Doxorubicin—bone cancer	7.04e-05	0.000841	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	6.97e-05	0.000816	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—DHFR—bone cancer	6.97e-05	0.000815	CbGpPWpGaD
Gemcitabine—RRM2—bone marrow—bone cancer	6.96e-05	0.0348	CbGeAlD
Gemcitabine—CMPK1—Metabolism—DHFR—bone cancer	6.94e-05	0.000812	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—DHFR—bone cancer	6.93e-05	0.00081	CbGpPWpGaD
Gemcitabine—Back pain—Epirubicin—bone cancer	6.9e-05	0.000825	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	6.89e-05	0.000806	CbGpPWpGaD
Gemcitabine—Angiopathy—Doxorubicin—bone cancer	6.88e-05	0.000823	CcSEcCtD
Gemcitabine—Malaise—Methotrexate—bone cancer	6.88e-05	0.000822	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—RFC1—bone cancer	6.87e-05	0.000804	CbGpPWpGaD
Gemcitabine—Immune system disorder—Doxorubicin—bone cancer	6.85e-05	0.000819	CcSEcCtD
Gemcitabine—Mediastinal disorder—Doxorubicin—bone cancer	6.84e-05	0.000817	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDK4—bone cancer	6.83e-05	0.000799	CbGpPWpGaD
Gemcitabine—Leukopenia—Methotrexate—bone cancer	6.83e-05	0.000816	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	6.81e-05	0.000797	CbGpPWpGaD
Gemcitabine—Chills—Doxorubicin—bone cancer	6.81e-05	0.000813	CcSEcCtD
Gemcitabine—Arrhythmia—Doxorubicin—bone cancer	6.78e-05	0.00081	CcSEcCtD
Gemcitabine—TYMS—G1/S Transition—RB1—bone cancer	6.75e-05	0.00079	CbGpPWpGaD
Gemcitabine—Nausea—Cisplatin—bone cancer	6.74e-05	0.000805	CcSEcCtD
Gemcitabine—Alopecia—Doxorubicin—bone cancer	6.7e-05	0.000801	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—DHFR—bone cancer	6.69e-05	0.000783	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	6.68e-05	0.000782	CbGpPWpGaD
Gemcitabine—Cough—Methotrexate—bone cancer	6.65e-05	0.000795	CcSEcCtD
Gemcitabine—Ill-defined disorder—Epirubicin—bone cancer	6.62e-05	0.000791	CcSEcCtD
Gemcitabine—Erythema—Doxorubicin—bone cancer	6.6e-05	0.000789	CcSEcCtD
Gemcitabine—Anaemia—Epirubicin—bone cancer	6.6e-05	0.000788	CcSEcCtD
Gemcitabine—RRM2—Metabolism—NT5C3A—bone cancer	6.59e-05	0.000771	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—RFC1—bone cancer	6.59e-05	0.000771	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	6.56e-05	0.000768	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NT5C3A—bone cancer	6.55e-05	0.000766	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDK4—bone cancer	6.54e-05	0.000765	CbGpPWpGaD
Gemcitabine—Arthralgia—Methotrexate—bone cancer	6.49e-05	0.000776	CcSEcCtD
Gemcitabine—Myalgia—Methotrexate—bone cancer	6.49e-05	0.000776	CcSEcCtD
Gemcitabine—Chest pain—Methotrexate—bone cancer	6.49e-05	0.000776	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—GNA11—bone cancer	6.49e-05	0.000759	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	6.45e-05	0.000771	CcSEcCtD
Gemcitabine—Malaise—Epirubicin—bone cancer	6.43e-05	0.000769	CcSEcCtD
Gemcitabine—Discomfort—Methotrexate—bone cancer	6.41e-05	0.000767	CcSEcCtD
Gemcitabine—POLA1—S Phase—RB1—bone cancer	6.39e-05	0.000748	CbGpPWpGaD
Gemcitabine—Leukopenia—Epirubicin—bone cancer	6.39e-05	0.000764	CcSEcCtD
Gemcitabine—Back pain—Doxorubicin—bone cancer	6.39e-05	0.000763	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—DHFR—bone cancer	6.23e-05	0.000729	CbGpPWpGaD
Gemcitabine—Cough—Epirubicin—bone cancer	6.23e-05	0.000744	CcSEcCtD
Gemcitabine—Anaphylactic shock—Methotrexate—bone cancer	6.22e-05	0.000744	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—DHFR—bone cancer	6.19e-05	0.000725	CbGpPWpGaD
Gemcitabine—Infection—Methotrexate—bone cancer	6.18e-05	0.000739	CcSEcCtD
Gemcitabine—Hypertension—Epirubicin—bone cancer	6.16e-05	0.000736	CcSEcCtD
Gemcitabine—DCK—Metabolism—NT5C3A—bone cancer	6.16e-05	0.00072	CbGpPWpGaD
Gemcitabine—Ill-defined disorder—Doxorubicin—bone cancer	6.13e-05	0.000732	CcSEcCtD
Gemcitabine—Nervous system disorder—Methotrexate—bone cancer	6.1e-05	0.000729	CcSEcCtD
Gemcitabine—Anaemia—Doxorubicin—bone cancer	6.1e-05	0.000729	CcSEcCtD
Gemcitabine—Thrombocytopenia—Methotrexate—bone cancer	6.09e-05	0.000728	CcSEcCtD
Gemcitabine—Myalgia—Epirubicin—bone cancer	6.07e-05	0.000726	CcSEcCtD
Gemcitabine—Chest pain—Epirubicin—bone cancer	6.07e-05	0.000726	CcSEcCtD
Gemcitabine—Arthralgia—Epirubicin—bone cancer	6.07e-05	0.000726	CcSEcCtD
Gemcitabine—Skin disorder—Methotrexate—bone cancer	6.04e-05	0.000723	CcSEcCtD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—bone cancer	6.03e-05	0.000706	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	6.03e-05	0.000721	CcSEcCtD
Gemcitabine—Hyperhidrosis—Methotrexate—bone cancer	6.02e-05	0.000719	CcSEcCtD
Gemcitabine—Discomfort—Epirubicin—bone cancer	6e-05	0.000717	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—DHFR—bone cancer	5.98e-05	0.0007	CbGpPWpGaD
Gemcitabine—RRM1—tendon—bone cancer	5.97e-05	0.0298	CbGeAlD
Gemcitabine—Malaise—Doxorubicin—bone cancer	5.95e-05	0.000712	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—RB1—bone cancer	5.94e-05	0.000695	CbGpPWpGaD
Gemcitabine—Anorexia—Methotrexate—bone cancer	5.93e-05	0.000709	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	5.92e-05	0.000692	CbGpPWpGaD
Gemcitabine—Leukopenia—Doxorubicin—bone cancer	5.91e-05	0.000706	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—CYP3A4—bone cancer	5.88e-05	0.000688	CbGpPWpGaD
Gemcitabine—Anaphylactic shock—Epirubicin—bone cancer	5.82e-05	0.000696	CcSEcCtD
Gemcitabine—Oedema—Epirubicin—bone cancer	5.82e-05	0.000696	CcSEcCtD
Gemcitabine—Hypotension—Methotrexate—bone cancer	5.81e-05	0.000695	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—bone cancer	5.79e-05	0.000678	CbGpPWpGaD
Gemcitabine—Infection—Epirubicin—bone cancer	5.79e-05	0.000692	CcSEcCtD
Gemcitabine—RRM1—bone marrow—bone cancer	5.78e-05	0.0289	CbGeAlD
Gemcitabine—Cough—Doxorubicin—bone cancer	5.76e-05	0.000689	CcSEcCtD
Gemcitabine—RRM1—spinal cord—bone cancer	5.75e-05	0.0288	CbGeAlD
Gemcitabine—Nervous system disorder—Epirubicin—bone cancer	5.71e-05	0.000683	CcSEcCtD
Gemcitabine—Thrombocytopenia—Epirubicin—bone cancer	5.7e-05	0.000682	CcSEcCtD
Gemcitabine—Hypertension—Doxorubicin—bone cancer	5.7e-05	0.000681	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—RB1—bone cancer	5.69e-05	0.000665	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Methotrexate—bone cancer	5.67e-05	0.000678	CcSEcCtD
Gemcitabine—Skin disorder—Epirubicin—bone cancer	5.66e-05	0.000676	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—bone cancer	5.64e-05	0.00066	CbGpPWpGaD
Gemcitabine—Hyperhidrosis—Epirubicin—bone cancer	5.63e-05	0.000673	CcSEcCtD
Gemcitabine—Insomnia—Methotrexate—bone cancer	5.63e-05	0.000673	CcSEcCtD
Gemcitabine—Chest pain—Doxorubicin—bone cancer	5.62e-05	0.000672	CcSEcCtD
Gemcitabine—Myalgia—Doxorubicin—bone cancer	5.62e-05	0.000672	CcSEcCtD
Gemcitabine—Arthralgia—Doxorubicin—bone cancer	5.62e-05	0.000672	CcSEcCtD
Gemcitabine—Paraesthesia—Methotrexate—bone cancer	5.59e-05	0.000668	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	5.58e-05	0.000667	CcSEcCtD
Gemcitabine—Discomfort—Doxorubicin—bone cancer	5.55e-05	0.000664	CcSEcCtD
Gemcitabine—Anorexia—Epirubicin—bone cancer	5.55e-05	0.000664	CcSEcCtD
Gemcitabine—Dyspnoea—Methotrexate—bone cancer	5.55e-05	0.000663	CcSEcCtD
Gemcitabine—Somnolence—Methotrexate—bone cancer	5.53e-05	0.000661	CcSEcCtD
Gemcitabine—Hypotension—Epirubicin—bone cancer	5.44e-05	0.00065	CcSEcCtD
Gemcitabine—Decreased appetite—Methotrexate—bone cancer	5.41e-05	0.000647	CcSEcCtD
Gemcitabine—TYMS—tendon—bone cancer	5.41e-05	0.027	CbGeAlD
Gemcitabine—Oedema—Doxorubicin—bone cancer	5.39e-05	0.000644	CcSEcCtD
Gemcitabine—Anaphylactic shock—Doxorubicin—bone cancer	5.39e-05	0.000644	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Methotrexate—bone cancer	5.37e-05	0.000642	CcSEcCtD
Gemcitabine—Fatigue—Methotrexate—bone cancer	5.37e-05	0.000641	CcSEcCtD
Gemcitabine—Infection—Doxorubicin—bone cancer	5.35e-05	0.00064	CcSEcCtD
Gemcitabine—Pain—Methotrexate—bone cancer	5.32e-05	0.000636	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Epirubicin—bone cancer	5.31e-05	0.000634	CcSEcCtD
Gemcitabine—Nervous system disorder—Doxorubicin—bone cancer	5.28e-05	0.000632	CcSEcCtD
Gemcitabine—Thrombocytopenia—Doxorubicin—bone cancer	5.28e-05	0.000631	CcSEcCtD
Gemcitabine—Insomnia—Epirubicin—bone cancer	5.27e-05	0.00063	CcSEcCtD
Gemcitabine—TYMS—bone marrow—bone cancer	5.24e-05	0.0262	CbGeAlD
Gemcitabine—Skin disorder—Doxorubicin—bone cancer	5.23e-05	0.000626	CcSEcCtD
Gemcitabine—Paraesthesia—Epirubicin—bone cancer	5.23e-05	0.000625	CcSEcCtD
Gemcitabine—TYMS—Metabolism—NDUFA12—bone cancer	5.21e-05	0.00061	CbGpPWpGaD
Gemcitabine—Hyperhidrosis—Doxorubicin—bone cancer	5.21e-05	0.000623	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—CHEK2—bone cancer	5.21e-05	0.000609	CbGpPWpGaD
Gemcitabine—Dyspnoea—Epirubicin—bone cancer	5.19e-05	0.000621	CcSEcCtD
Gemcitabine—Somnolence—Epirubicin—bone cancer	5.18e-05	0.000619	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—CHEK2—bone cancer	5.18e-05	0.000606	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.17e-05	0.000605	CbGpPWpGaD
Gemcitabine—Anorexia—Doxorubicin—bone cancer	5.14e-05	0.000614	CcSEcCtD
Gemcitabine—Feeling abnormal—Methotrexate—bone cancer	5.13e-05	0.000613	CcSEcCtD
Gemcitabine—Decreased appetite—Epirubicin—bone cancer	5.06e-05	0.000605	CcSEcCtD
Gemcitabine—Hypotension—Doxorubicin—bone cancer	5.04e-05	0.000602	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—GSTP1—bone cancer	5.03e-05	0.000589	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Epirubicin—bone cancer	5.03e-05	0.000601	CcSEcCtD
Gemcitabine—Fatigue—Epirubicin—bone cancer	5.02e-05	0.0006	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—CHEK2—bone cancer	5e-05	0.000585	CbGpPWpGaD
Gemcitabine—Pain—Epirubicin—bone cancer	4.98e-05	0.000595	CcSEcCtD
Gemcitabine—Constipation—Epirubicin—bone cancer	4.98e-05	0.000595	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.95e-05	0.00058	CbGpPWpGaD
Gemcitabine—Body temperature increased—Methotrexate—bone cancer	4.92e-05	0.000588	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Doxorubicin—bone cancer	4.91e-05	0.000587	CcSEcCtD
Gemcitabine—Insomnia—Doxorubicin—bone cancer	4.87e-05	0.000583	CcSEcCtD
Gemcitabine—SLC29A1—tendon—bone cancer	4.85e-05	0.0243	CbGeAlD
Gemcitabine—Paraesthesia—Doxorubicin—bone cancer	4.84e-05	0.000578	CcSEcCtD
Gemcitabine—Dyspnoea—Doxorubicin—bone cancer	4.8e-05	0.000574	CcSEcCtD
Gemcitabine—Feeling abnormal—Epirubicin—bone cancer	4.8e-05	0.000574	CcSEcCtD
Gemcitabine—Somnolence—Doxorubicin—bone cancer	4.79e-05	0.000573	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—DHFR—bone cancer	4.77e-05	0.000558	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—CDK4—bone cancer	4.76e-05	0.000557	CbGpPWpGaD
Gemcitabine—SLC29A1—bone marrow—bone cancer	4.7e-05	0.0235	CbGeAlD
Gemcitabine—Decreased appetite—Doxorubicin—bone cancer	4.68e-05	0.00056	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Doxorubicin—bone cancer	4.65e-05	0.000556	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.65e-05	0.000544	CbGpPWpGaD
Gemcitabine—Fatigue—Doxorubicin—bone cancer	4.65e-05	0.000555	CcSEcCtD
Gemcitabine—DCK—tendon—bone cancer	4.63e-05	0.0232	CbGeAlD
Gemcitabine—CDA—Metabolism—ENO2—bone cancer	4.62e-05	0.000541	CbGpPWpGaD
Gemcitabine—Constipation—Doxorubicin—bone cancer	4.61e-05	0.000551	CcSEcCtD
Gemcitabine—Pain—Doxorubicin—bone cancer	4.61e-05	0.000551	CcSEcCtD
Gemcitabine—Body temperature increased—Epirubicin—bone cancer	4.6e-05	0.00055	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—DHFR—bone cancer	4.57e-05	0.000534	CbGpPWpGaD
Gemcitabine—DCK—bone marrow—bone cancer	4.49e-05	0.0224	CbGeAlD
Gemcitabine—DCK—spinal cord—bone cancer	4.47e-05	0.0223	CbGeAlD
Gemcitabine—Asthenia—Methotrexate—bone cancer	4.46e-05	0.000534	CcSEcCtD
Gemcitabine—Feeling abnormal—Doxorubicin—bone cancer	4.44e-05	0.000531	CcSEcCtD
Gemcitabine—ABCC10—tendon—bone cancer	4.41e-05	0.0221	CbGeAlD
Gemcitabine—RRM2—Cell Cycle—BRCA2—bone cancer	4.41e-05	0.000516	CbGpPWpGaD
Gemcitabine—Pruritus—Methotrexate—bone cancer	4.4e-05	0.000526	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—BRCA2—bone cancer	4.39e-05	0.000513	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NT5C3A—bone cancer	4.32e-05	0.000505	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—DHFR—bone cancer	4.29e-05	0.000502	CbGpPWpGaD
Gemcitabine—ABCC10—bone marrow—bone cancer	4.28e-05	0.0214	CbGeAlD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	4.27e-05	0.0005	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—DHFR—bone cancer	4.26e-05	0.000499	CbGpPWpGaD
Gemcitabine—Body temperature increased—Doxorubicin—bone cancer	4.26e-05	0.000509	CcSEcCtD
Gemcitabine—ABCC10—spinal cord—bone cancer	4.26e-05	0.0213	CbGeAlD
Gemcitabine—Diarrhoea—Methotrexate—bone cancer	4.26e-05	0.000509	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—BRCA2—bone cancer	4.24e-05	0.000496	CbGpPWpGaD
Gemcitabine—Asthenia—Epirubicin—bone cancer	4.18e-05	0.000499	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—bone cancer	4.13e-05	0.000483	CbGpPWpGaD
Gemcitabine—Pruritus—Epirubicin—bone cancer	4.12e-05	0.000493	CcSEcCtD
Gemcitabine—POLE—Mitotic M-M/G1 phases—RB1—bone cancer	4.08e-05	0.000478	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—DHFR—bone cancer	4.08e-05	0.000478	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GNA11—bone cancer	4.01e-05	0.000469	CbGpPWpGaD
Gemcitabine—Diarrhoea—Epirubicin—bone cancer	3.98e-05	0.000476	CcSEcCtD
Gemcitabine—Vomiting—Methotrexate—bone cancer	3.96e-05	0.000473	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—bone cancer	3.95e-05	0.000463	CbGpPWpGaD
Gemcitabine—Rash—Methotrexate—bone cancer	3.92e-05	0.000469	CcSEcCtD
Gemcitabine—Dermatitis—Methotrexate—bone cancer	3.92e-05	0.000469	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.91e-05	0.000457	CbGpPWpGaD
Gemcitabine—Headache—Methotrexate—bone cancer	3.9e-05	0.000466	CcSEcCtD
Gemcitabine—Asthenia—Doxorubicin—bone cancer	3.87e-05	0.000462	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.83e-05	0.000449	CbGpPWpGaD
Gemcitabine—Pruritus—Doxorubicin—bone cancer	3.81e-05	0.000456	CcSEcCtD
Gemcitabine—Vomiting—Epirubicin—bone cancer	3.7e-05	0.000443	CcSEcCtD
Gemcitabine—Nausea—Methotrexate—bone cancer	3.7e-05	0.000442	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.7e-05	0.000433	CbGpPWpGaD
Gemcitabine—Diarrhoea—Doxorubicin—bone cancer	3.69e-05	0.000441	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.67e-05	0.00043	CbGpPWpGaD
Gemcitabine—Rash—Epirubicin—bone cancer	3.67e-05	0.000439	CcSEcCtD
Gemcitabine—Dermatitis—Epirubicin—bone cancer	3.67e-05	0.000439	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDK4—bone cancer	3.66e-05	0.000428	CbGpPWpGaD
Gemcitabine—Headache—Epirubicin—bone cancer	3.65e-05	0.000436	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDK4—bone cancer	3.64e-05	0.000426	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CYP3A4—bone cancer	3.63e-05	0.000425	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CHEK2—bone cancer	3.56e-05	0.000417	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.54e-05	0.000414	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDK4—bone cancer	3.51e-05	0.000411	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ENO2—bone cancer	3.5e-05	0.00041	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	3.5e-05	0.000409	CbGpPWpGaD
Gemcitabine—Nausea—Epirubicin—bone cancer	3.46e-05	0.000413	CcSEcCtD
Gemcitabine—Vomiting—Doxorubicin—bone cancer	3.43e-05	0.00041	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—CHEK2—bone cancer	3.41e-05	0.000399	CbGpPWpGaD
Gemcitabine—Rash—Doxorubicin—bone cancer	3.4e-05	0.000406	CcSEcCtD
Gemcitabine—Dermatitis—Doxorubicin—bone cancer	3.39e-05	0.000406	CcSEcCtD
Gemcitabine—Headache—Doxorubicin—bone cancer	3.38e-05	0.000404	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.33e-05	0.00039	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDK4—bone cancer	3.27e-05	0.000383	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDK4—bone cancer	3.25e-05	0.000381	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—DHFR—bone cancer	3.25e-05	0.00038	CbGpPWpGaD
Gemcitabine—Nausea—Doxorubicin—bone cancer	3.2e-05	0.000383	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.19e-05	0.000374	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—RB1—bone cancer	3.18e-05	0.000372	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—RB1—bone cancer	3.16e-05	0.00037	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDK4—bone cancer	3.14e-05	0.000368	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSTP1—bone cancer	3.11e-05	0.000364	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—JUN—bone cancer	3.07e-05	0.000359	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—RB1—bone cancer	3.06e-05	0.000358	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GNA11—bone cancer	3.04e-05	0.000356	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—BRCA2—bone cancer	3.02e-05	0.000353	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	2.97e-05	0.000348	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—RB1—bone cancer	2.91e-05	0.000341	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—BRCA2—bone cancer	2.89e-05	0.000338	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ENO2—bone cancer	2.89e-05	0.000338	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ENO2—bone cancer	2.87e-05	0.000336	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—RB1—bone cancer	2.85e-05	0.000333	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—RB1—bone cancer	2.83e-05	0.000331	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP3A4—bone cancer	2.75e-05	0.000322	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—RB1—bone cancer	2.73e-05	0.00032	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	2.71e-05	0.000317	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ENO2—bone cancer	2.7e-05	0.000316	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—DHFR—bone cancer	2.68e-05	0.000313	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—DHFR—bone cancer	2.66e-05	0.000311	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.62e-05	0.000307	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—bone cancer	2.61e-05	0.000305	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.51e-05	0.000294	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDK4—bone cancer	2.5e-05	0.000293	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GNA11—bone cancer	2.5e-05	0.000293	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—DHFR—bone cancer	2.5e-05	0.000293	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GNA11—bone cancer	2.49e-05	0.000291	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	2.47e-05	0.000289	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	2.43e-05	0.000285	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MDM2—bone cancer	2.43e-05	0.000284	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MDM2—bone cancer	2.41e-05	0.000282	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDK4—bone cancer	2.4e-05	0.000281	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTP1—bone cancer	2.36e-05	0.000276	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GNA11—bone cancer	2.34e-05	0.000274	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MDM2—bone cancer	2.33e-05	0.000273	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	2.31e-05	0.00027	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP3A4—bone cancer	2.27e-05	0.000265	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP3A4—bone cancer	2.25e-05	0.000264	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDK4—bone cancer	2.24e-05	0.000262	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.2e-05	0.000257	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—RB1—bone cancer	2.18e-05	0.000255	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDK4—bone cancer	2.14e-05	0.000251	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP3A4—bone cancer	2.12e-05	0.000248	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.11e-05	0.000247	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—RB1—bone cancer	2.09e-05	0.000244	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	2.06e-05	0.000241	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.06e-05	0.000241	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—bone cancer	2.02e-05	0.000237	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—RB1—bone cancer	1.95e-05	0.000228	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTP1—bone cancer	1.94e-05	0.000227	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTP1—bone cancer	1.93e-05	0.000226	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ENO2—bone cancer	1.89e-05	0.000221	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—RB1—bone cancer	1.86e-05	0.000218	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTP1—bone cancer	1.81e-05	0.000212	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.77e-05	0.000208	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—DHFR—bone cancer	1.75e-05	0.000205	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MDM2—bone cancer	1.66e-05	0.000194	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GNA11—bone cancer	1.64e-05	0.000192	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—bone cancer	1.61e-05	0.000188	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NDUFA12—bone cancer	1.61e-05	0.000188	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MDM2—bone cancer	1.59e-05	0.000186	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	1.53e-05	0.000179	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP3A4—bone cancer	1.49e-05	0.000174	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—bone cancer	1.39e-05	0.000163	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—bone cancer	1.38e-05	0.000162	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—bone cancer	1.34e-05	0.000156	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NT5C3A—bone cancer	1.33e-05	0.000156	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTP1—bone cancer	1.27e-05	0.000149	CbGpPWpGaD
Gemcitabine—ABCB1—bone marrow—bone cancer	1.23e-05	0.00617	CbGeAlD
Gemcitabine—ABCB1—spinal cord—bone cancer	1.23e-05	0.00615	CbGeAlD
Gemcitabine—RRM1—Metabolism—PTGS2—bone cancer	1.22e-05	0.000143	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	1.13e-05	0.000133	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.09e-05	0.000128	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—bone cancer	1e-05	0.000118	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—bone cancer	9.99e-06	0.000117	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	9.85e-06	0.000115	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—bone cancer	9.52e-06	0.000111	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—bone cancer	9.39e-06	0.00011	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—bone cancer	9.12e-06	0.000107	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	7.75e-06	9.06e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—bone cancer	6.59e-06	7.71e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	6.5e-06	7.61e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ENO2—bone cancer	5.83e-06	6.83e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—DHFR—bone cancer	5.41e-06	6.33e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GNA11—bone cancer	5.06e-06	5.92e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP3A4—bone cancer	4.59e-06	5.37e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTP1—bone cancer	3.92e-06	4.59e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—bone cancer	2.03e-06	2.38e-05	CbGpPWpGaD
